Spherical Nucleic Acid Architecture Can Improve the Efficacy of Polycation-Mediated SiRNA Delivery

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2018 Sep 10

PMID 30195760

Citations 26

Authors

Jilian R Melamed

Nicole L Kreuzberger

Ritu Goyal

Emily S Day

Affiliations

Soon will be listed here.

Abstract

Clinical translation of small interfering RNA (siRNA) nanocarriers is hindered by limited knowledge regarding the parameters that regulate interactions between nanocarriers and biological systems. To address this, we investigated the influence of polycation-based nanocarrier architecture on intracellular siRNA delivery. We compared the cellular interactions of two polycation-based siRNA carriers that have similar size and surface charge but different siRNA orientation: (1) polyethylenimine-coated spherical nucleic acids (PEI-SNAs), in which polyethylenimine is wrapped around a spherical nucleic acid core containing radially oriented siRNA and (2) randomly assembled polyethylenimine-siRNA polyplexes that lack controlled architecture. We found that PEI-SNAs undergo enhanced and more rapid cellular uptake than polyplexes, suggesting a prominent role for architecture in cellular uptake. Confocal microscopy studies demonstrated that while PEI-SNAs and polyplexes exhibit similar intracellular stability, PEI-SNAs undergo decreased accumulation within lysosomes, identifying another advantage conferred by their architecture. Indeed, these advantageous cellular interactions enhanced the gene silencing potency of PEI-SNAs by 10-fold relative to polyplexes. Finally, cytocompatibility studies showed that PEI-SNAs exhibit decreased toxicity per PEI content relative to polyplexes, allowing the use of more polycation. Our studies provide critical insight into design considerations for engineering siRNA carriers and warrant future investigation of how nanocarrier architecture influences cellular-, organ-, and organism-level interactions.

Citing Articles

Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies.

Martinez Junior A, Ruiz T, Vilamaior P, Tiera V, Taboga S, Tiera M Drug Deliv Transl Res. 2025; .

PMID: 39907973 DOI: 10.1007/s13346-025-01800-4.

Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem-Like Behavior in Triple-Negative Breast Cancer Cells.

Hoover E, Day E J Biomed Mater Res A. 2025; 113(1):e37867.

PMID: 39760151 PMC: 11800355. DOI: 10.1002/jbm.a.37867.

Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.

Valatabar N, Oroojalian F, Kazemzadeh M, Mokhtarzadeh A, Safaralizadeh R, Sahebkar A J Nanobiotechnology. 2024; 22(1):386.

PMID: 38951806 PMC: 11218236. DOI: 10.1186/s12951-024-02648-5.

Improving DNA nanostructure stability: A review of the biomedical applications and approaches.

Nasiri M, Bahadorani M, Dellinger K, Aravamudhan S, Vivero-Escoto J, Zadegan R Int J Biol Macromol. 2024; 260(Pt 1):129495.

PMID: 38228209 PMC: 11060068. DOI: 10.1016/j.ijbiomac.2024.129495.

Enhancing Endosomal Escape and Gene Regulation Activity for Spherical Nucleic Acids.

Park J, Evangelopoulos M, Vasher M, Kudruk S, Ramani N, Mayer V Small. 2023; 20(11):e2306902.

PMID: 37932003 PMC: 10947971. DOI: 10.1002/smll.202306902.

References

Barnaby S, Lee A, Mirkin C . Probing the inherent stability of siRNA immobilized on nanoparticle constructs. Proc Natl Acad Sci U S A. 2014; 111(27):9739-44. PMC: 4103361. DOI: 10.1073/pnas.1409431111. View

Zintchenko A, Philipp A, Dehshahri A, Wagner E . Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem. 2008; 19(7):1448-55. DOI: 10.1021/bc800065f. View

Elbakry A, Zaky A, Liebl R, Rachel R, Goepferich A, Breunig M . Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009; 9(5):2059-64. DOI: 10.1021/nl9003865. View

Wittrup A, Lieberman J . Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet. 2015; 16(9):543-52. PMC: 4756474. DOI: 10.1038/nrg3978. View

Lee J, Green J, Love K, Sunshine J, Langer R, Anderson D . Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009; 9(6):2402-6. PMC: 2728206. DOI: 10.1021/nl9009793. View

Pi F, Binzel D, Lee T, Li Z, Sun M, Rychahou P . Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol. 2017; 13(1):82-89. PMC: 5762263. DOI: 10.1038/s41565-017-0012-z. View

Grayson A, Doody A, Putnam D . Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res. 2006; 23(8):1868-76. DOI: 10.1007/s11095-006-9009-2. View

Zheng M, Pavan G, Neeb M, Schaper A, Danani A, Klebe G . Targeting the blind spot of polycationic nanocarrier-based siRNA delivery. ACS Nano. 2012; 6(11):9447-54. PMC: 3882193. DOI: 10.1021/nn301966r. View

Chinen A, Guan C, Mirkin C . Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions. Angew Chem Int Ed Engl. 2014; 54(2):527-31. PMC: 4314381. DOI: 10.1002/anie.201409211. View

10.

Seferos D, Prigodich A, Giljohann D, Patel P, Mirkin C . Polyvalent DNA nanoparticle conjugates stabilize nucleic acids. Nano Lett. 2008; 9(1):308-11. PMC: 3918421. DOI: 10.1021/nl802958f. View

11.

Gratton S, Ropp P, Pohlhaus P, Luft J, Madden V, Napier M . The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008; 105(33):11613-8. PMC: 2575324. DOI: 10.1073/pnas.0801763105. View

12.

Wittrup A, Ai A, Liu X, Hamar P, Trifonova R, Charisse K . Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol. 2015; 33(8):870-6. PMC: 4663660. DOI: 10.1038/nbt.3298. View

13.

Day E, Thompson P, Zhang L, Lewinski N, Ahmed N, Drezek R . Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol. 2010; 104(1):55-63. PMC: 3710584. DOI: 10.1007/s11060-010-0470-8. View

14.

Day E, Zhang L, Thompson P, Zawaski J, Kaffes C, Gaber M . Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012; 7(8):1133-48. PMC: 5375028. DOI: 10.2217/nnm.11.189. View

15.

Wu X, Choi C, Zhang C, Hao L, Mirkin C . Intracellular fate of spherical nucleic acid nanoparticle conjugates. J Am Chem Soc. 2014; 136(21):7726-33. PMC: 4046773. DOI: 10.1021/ja503010a. View

16.

Nicoli E, Syga M, Bosetti M, Shastri V . Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes. PLoS One. 2015; 10(4):e0122581. PMC: 4391875. DOI: 10.1371/journal.pone.0122581. View

17.

Varkouhi A, Mountrichas G, Schiffelers R, Lammers T, Storm G, Pispas S . Polyplexes based on cationic polymers with strong nucleic acid binding properties. Eur J Pharm Sci. 2011; 45(4):459-66. DOI: 10.1016/j.ejps.2011.09.002. View

18.

Goyal R, Tripathi S, Vazquez E, Kumar P, Gupta K . Biodegradable poly(vinyl alcohol)-polyethylenimine nanocomposites for enhanced gene expression in vitro and in vivo. Biomacromolecules. 2011; 13(1):73-83. DOI: 10.1021/bm201157f. View

19.

Jensen S, Day E, Ko C, Hurley L, Luciano J, Kouri F . Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med. 2013; 5(209):209ra152. PMC: 4017940. DOI: 10.1126/scitranslmed.3006839. View

20.

Whitehead K, Langer R, Anderson D . Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009; 8(2):129-38. PMC: 7097568. DOI: 10.1038/nrd2742. View